Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2-3.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Jul 2020

Gonzalez-Bosquet Eduardo, Gibert Monica, Serra Mariona, Hernandez-Saborit Alicia, Gonzalez-Fernandez Alba

Abstract excerpt

OBJECTIVES: To identify the prevalence of human papillomavirus genotypes - as a single infection or co-infection - not included in the 9-valent (9v) HPV vaccine among women with cervical intraepithelial neoplasia (CIN 2-3). METHODS: Retrospective study of 1700 women referred due to abnormal cytology to Sant Joan de Deu Hospital. We selected 849 patients with CIN 2 or CIN 3 diagnosis confirmed by biopsy. An HPV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Papillomavirus Vaccines

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Share to Young Adult

Source

Identifiers

PMID: 32467333
DOI: 10.1136/ijgc-2019-001069

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2-3.PMID 32467333Read ↗

Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.Semantic proximity Read ↗

Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3).Semantic proximity Read ↗

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.Semantic proximity Read ↗

Respective prevalence of high-risk HPVgenotypes in cervical neoplasia in Senegal.Semantic proximity Read ↗

HPV genotypes in CIN 2-3 lesions and cervical cancer: a population-based study.Semantic proximity Read ↗

Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.Semantic proximity Read ↗

Potential impact of introducing a nonavalent HPV vaccination.Semantic proximity Read ↗

Repeated Detection of Vaccine-Preventable Anal HPV Genotypes in a Screened Cohort: A Retrospective Observational Study.Semantic proximity Read ↗

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.Semantic proximity Read ↗

Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes.Semantic proximity Read ↗

Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis.Semantic proximity Read ↗

Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.